The human HSTI gene, previously designated the hst gene, and now assigned the name HSTFI for heparin-binding secretory transforming factor in human gene nomenclature, was originally identified as a transforming gene in DNAs from human stomach cancers by transfection assay with mouse NIH 3T3 cells. The amino acid sequence of the product deduced from DNA sequences of the HSTI cDNA and genomic clones had approximately 40% homology to human basic and acidic fibroblast growth factors and mouse Int-2-encoded protein. We have mapped the human HSTI gene to chromosome 11 at band q13.3 by Southern blot hybridization analysis of a panel of human and mouse somatic cell hybrids and in situ hybridization with an HSTI cDNA probe. The HSTI gene was found to be amplified in DNAs obtained from a stomach cancer and a vulvar carcinoma cell line, A431. In all of these samples of DNA, the INT2 gene, previously mapped to human chromosome 11q13, was also amplified to the same degree as the HSTI gene.
The HSTI gene, now assigned the name HSTFJ for heparinbinding secretory transforming factor in human gene nomenclature, was originally identified as a transforming gene (hst) in DNAs from human stomach cancers and a noncancerous portion of human stomach mucosa by transfection assay using mouse NIH 3T3 cells (1) . The HST gene was subsequently identified as a transforming gene in stomach cancers from the other patients (2) and also in other types of cancers (2) (3) (4) . The KS oncogene, recently identified as a transforming gene in DNA from a Kaposi's sarcoma, has been shown to be the HST gene (5, 6) . The HST gene is at present the most frequently found transforming gene next to the RAS gene family. Cosmid clones containing the genomic HST from leukocyte DNA of a patient with leukemia (7) and a normal person (27) were shown to have transforming activity with NIH 3T3 cells upon transfection.
In addition to the previously described HST gene, the human genome contains another DNA sequence that hybridized to the HST cDNA. In this paper, we designate the previously described HSTgene that has transforming activity the HSTI gene. The other DNA sequence that hybridized to the HST cDNA probe is designated the HS72 gene. The HS72 gene may represent a pseudogene or a gene belonging to the HST gene family. Clones containing either the HSTI gene or the HS72 gene have been obtained (9, 27) . The 206-amino acid sequence of the HST encoded protein deduced from DNA sequences of the HST1 cDNA (8) and the genomic HSTI has significant homology to selected regions of human basic fibroblast growth factor (FGF), human acidic FGF, and mouse Int-2-encoded protein, respectively (9) . FGFs are potent mitogens, and the mouse Int-2 gene is considered to be involved in development of mouse mammary cancers induced by murine mammary tumor virus (10) (11) (12) .
Here, we report that the HSTI gene maps to human chromosome 11 at band q13.3 and that this gene is coamplified with INT2 in some human cancers. The human INT2 gene was previously mapped to chromosome 11 at band q13 (10). The results indicated that at least two of the genes encoding the FGF family are located closely on chromosome 11 at band q13.
MATERIALS AND METHODS
DNA Probes. The isolation, characterization, and DNA sequencing of the HST1 cDNA from T361-2nd-1 cells, a secondary transformant obtained by transfection of a stomach cancer DNA, and those of the HSTI gene have been described (1, 8 (14) . Cytogenetic analyses by Q-banding were used to determine the human chromosome complement. High molecular weight DNA for Southern blot and cytogenetic analyses was prepared from hybrid cells at the same stage of passaging as described (1, 14, 15) .
In Situ Hybridization. Metaphase spreads were obtained from phytohemagglutinin-stimulated peripheral blood lymphocytes from a normal male as described (14) . Before hybridization, the chromosome preparations were pretreated with RNase and denatured in 70% formamide/0.30 M sodium chloride/0.030 M sodium citrate at 70°C. The probe was 3H-labeled by nick translation to a specific activity of 1-5 x 107 dpm/,ug and used for hybridization at a concentration of Abbreviation: FGF, fibroblast growth factor.
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3 Ag/ml. Hybridization, washing, and autoradiography were carried out essentially as described (16) (1, 15) . DNAs were also isolated from 22 cell lines including a vulvar carcinoma cell line, A431 (19) , and a colon carcinoma cell line, COLO 205 (20) . Southern blot hybridization analyses of these DNA samples were performed as described (1, 21) . Washing of the filters to remove the probe and to allow reutilization for hybridization with several different probes was performed as described (21) . To ascertain that equal amounts of DNA were loaded in each lane, the filter was hybridized with several probes unrelated to these genes.
RESULTS
Chromosomal Localization of the HSTI Gene. Hybridization with the HST1 cDNA probe AA to Southern blots of EcoRI-digested human DNA revealed four DNA fragments of 8.0, 5.8, 2.8, and 0.8 kbp (Fig. 1) . Three of these four fragments, 5.8, 2.8, and 0.8 kbp, correspond to the sequences contained in the HSTI gene, while the 8.0-kbp fragment corresponds to a sequence in the HST2 gene. When EcoRIdigests of mouse DNA were hybridized with the HST1 cDNA probe AA, three bands of 6.7, 4.4, and 1.8 kbp were detected. Therefore, it was possible to identify the human HSTI sequence in the DNA from mouse-human hybrid cell lines containing different human chromosomes. An analysis of the segregation of EcoRI-digested DNA fragments of the human HSTI gene in a total number of 27 hybrid cell clones showed concordance between the presence of the human HSTI gene and human chromosome 11, whereas discordance was found with all other human chromosomes (Fig. 1) .
The genomic HSTI probe b hybridized only to the 5. analyzed by Southern blot hybridization with the HST1 cDNA probe AA. In all of these DNA samples, the probe detected 8.0-, 5.8-, 2.8-, and 0.8-kbp EcoRI-EcoRI fragments, indicating that there was no gross rearrangement of the HSTI and HST2 genes. However, in DNAs from a lymph node metastasis of a stomach cancer of patient SC6 and from A431 cells, the signals corresponding to the HSTI-specific 5.8-, 2.8-, and 0.8-kbp fragments were much more intense than those in DNAs from normal tissues or other cultured cell lines, which include COLO 205, a colon carcinoma cell line (Fig. 3) . The primary tumor from the patient SC6 also contained the amplified HSTI gene (data not shown). It should be noted that the intensity of the band corresponding to the 8.0-kbp fragment of the HST2 gene was the same in these samples of DNAs as that in DNAs from normal tissues and COLO 205 cells. The degree of amplification of the HSTI gene was approximately 6-fold for DNAs from both primary tumor and the lymph node metastasis of a stomach cancer patient, SC6, and 3-fold for DNA from A431 cells when they were determined by quantitative comparison of the HSTI fragments between serially diluted amounts of DNAs of the tumors or the cell line and those of normal tissues. This stomach cancer with the amplified HSTJ gene was 1 of the 19 poorly differentiated stomach adenocarcinomas examined.
These samples of DNA were analyzed with an INT2 probe, BB4 or SS6, after digestion with Bcl I or EcoRI, respectively. Upon BcR I digestion, human genomic DNA exhibited one band of 9.0 kbp with BB4 as a probe, whereas EcoRI-digests of human DNA showed one band of 10 kbp with SS6 as a probe. DNA samples, containing the amplified HSTI gene, from the primary tumor and lymph node metastasis of stomach cancer patient SC6 and A431 cells showed amplification of the INT2 gene, with the degree of amplification being the same as that of the HSTJ gene. Neither the HSTI gene nor INT2 gene was amplified in the other 62 samples of DNAs tested. In the 3 DNA samples with coamplification of the HSTI gene and the INT2 gene, there was no amplification of the HRAS gene or the ETSI gene (data not shown), the chromosomal localizations of which are on the short arm and long arm of chromosome 11, respectively. The results indicate that the amplification was not due to an increase in number of chromosomes 11.
DISCUSSION
We have assigned the HSTJ gene to chromosome 11 based on the pattern obtained when a human HST1 cDNA probe was hybridized to a panel of DNAs isolated from mouse-human somatic cell hybrids. The gene was sublocalized to chromosome 11 at band q13.3 by in situ hybridization with a genomic fragment ofthe HSTgene that hybridized to the HSTI but not to the HST2 gene.
Human DNA contained two types of DNA fragments hybridizing to the HST1 cDNA probe AA, which encompasses almost the entire sequence of open reading frame 1: one is the HSTI gene and the other is the HST2 gene. Upon digestion with EcoRI, the HSTI gene generated 5. that no amplification of the HST2 gene was detected in DNA samples with amplified HSTI gene further confirmed the presence of two distinct types of HST genes. The HST2 gene might be a pseudogene or a novel gene related to the HSTJ gene. A genomic fragment ofthe HSTJ gene obtained directly from a human genomic library also had transforming activity (7, 9) . This fragment had a coding sequence identical to that ofthe open reading frame 1 ofthe HST1 cDNA prepared from T361-2nd-1 cells. The deduced amino acid sequence of the HSTI-encoded protein of 206 amino acid residues is 43%, 38%, and 40% homologous, respectively, to human basic FGF (22, 23) , human acidic FGF (24) , and mouse Int-2 protein (25) in selected regions. This group may constitute a family of genes encoding various types of growth factors (9, 26) . There is, however, a distinct difference between the HSTI-encoded protein and FGFs; the HST1 protein contains, but FGFs do not contain, a signal peptide, and this presence of the signal peptide may be essential for the acquisition of transforming activity (9) . It was recently demonstrated that the gene for basic FGF, FGFB, when fused to a sequence for a signal peptide, transformed NIH 3T3 cells upon transfection (26) .
Murine mammary tumor virus proviral DNA inserted in the mouse Int-2 locus activates expression of the mouse Int-2 gene located within this locus, whose protein product may be involved in the genesis of murine mammary carcinomas (10) (11) (12) (13) . The mouse Int-2-encoded protein has homology with the human HSTJ-encoded protein (9) . The human INT2 gene, the human homologue of the mouse Int-2 gene, was previously mapped to chromosome 11 at band q13 (13), which was shown to contain the HSTI gene in the present study. In three DNA samples, coamplification of the HSTJ gene and the IN72 gene was detected, indicating that these two genes were (lanes 1 and 2) , and SS6 was used as an INT2 probe for analysis of EcoRI-digested DNAs (lanes 3 and 4) . HindIl-digested A phage DNA was used as a slize marker. localized closely in chromosome 11 at band q13 and amplified together as one "amplicon" unit. It is possible that there may be a cluster of the HSTI-or IN12-related genes in this region of chromosome 11q13, the products of which are factors involved in regulation of cell growth for various types of normal and malignant cells.
